HapticV1, PascalFrancis, Corpus, bibRecord, 001637

Clinical evaluation of the Unfolder

Identifieur interne : 001637 ( PascalFrancis/Corpus ); précédent : 001636; suivant : 001638

Clinical evaluation of the Unfolder

Auteurs : R. Olson ; R. Cameron ; T. Hovis ; J. Hunkeler ; R. Lindstrom ; R. Steinert

Source :

Journal of cataract and refractive surgery [ 0886-3350 ] ; 1997.

RBID : Pascal:98-0039954

Descripteurs français

Pascal (Inist)
- Lentille intraoculaire, Implantation, Technique, Appareil, Déploiement, Efficacité, Sécurité, Homme.

English descriptors

KwdEn :
- Apparatus, Efficiency, Human, Implantation, Intraocular lens, Safety, Technique, Unfolding.

Abstract

Purpose: To evaluate the clinical acceptability of the Unfolder for implantation of AMO® PhacoFlex II® (model SI-30NB or SI-40NB) intraocular lenses (lOLs). Setting: Six investigational sites in five states in the United States: Utah, Texas, Missouri, Minnesota, and Massachusetts. Methods: One hundred one patients from six investigational sites had implantation of an SI-30NB or SI-40NB IOL. Investigators evaluated the clinical acceptability of the Unfolder by comparing their experience with the injector with that using other implantation systems. Internal incision size (dimensions) was measured three times during surgery using a calibrated instrument. Data on safety and efficacy were collected. Results: The investigators rated the Unfolder as clinically acceptable. Mean internal incision size after phacoemulsification but before IOL implantation was 3.0 mm ± 0.1 (SD) (range 2.7 to 3.2 mm). Average internal incision size after IOL implantation was 3.1 ± 0.1 mm. There were no reports of haptic deformation, lens optic damage, or postoperative complications related to the Unfolder. No adverse events were reported. Conclusions: Investigators found the Unfolder easy to use. It provided controlled lens implantation through incisions 2.7 to 3.2 mm, with post-IOL implantation incisions ranging from 2.9 to 3.3 mm.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0886-3350`
A02	`01`			`@0 JCSUEV`
A03		`1`		`@0 J. cataract refractive surg.`
A05				`@2 23`
A06				`@2 9`
A08	`01`	`1`	`ENG`	`@1 Clinical evaluation of the Unfolder`
A11	`01`	`1`		`@1 OLSON (R.)`
A11	`02`	`1`		`@1 CAMERON (R.)`
A11	`03`	`1`		`@1 HOVIS (T.)`
A11	`04`	`1`		`@1 HUNKELER (J.)`
A11	`05`	`1`		`@1 LINDSTROM (R.)`
A11	`06`	`1`		`@1 STEINERT (R.)`
A14	`01`			`@1 University of Utah @2 Salt Lake City, Utah @3 USA @Z 1 aut.`
A14	`02`			`@1 Abilene Regional Medical Center @2 Abilene, Texas @3 USA @Z 2 aut.`
A14	`03`			`@1 Columbus Community Hospital @2 Columbus, Texas @3 USA @Z 3 aut.`
A14	`04`			`@1 University of Kansas/Kansas City @2 Kansas City, Missouri @3 USA @Z 4 aut.`
A14	`05`			`@1 Phillips Eye Institute @2 Minneapolis, Minnesota @3 USA @Z 5 aut.`
A14	`06`			`@1 Harvard Medical School @2 Boston, Massachusetts @3 USA @Z 6 aut.`
A20				`@1 1384-1389`
A21				`@1 1997`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20937 @5 354000079687470160`
A44				`@0 0000 @1 © 1998 INIST-CNRS. All rights reserved.`
A45				`@0 5 ref.`
A47	`01`	`1`		`@0 98-0039954`
A60				`@1 P`
A61				`@0 A`
A64		`1`		`@0 Journal of cataract and refractive surgery`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Purpose: To evaluate the clinical acceptability of the Unfolder for implantation of AMO® PhacoFlex II® (model SI-30NB or SI-40NB) intraocular lenses (lOLs). Setting: Six investigational sites in five states in the United States: Utah, Texas, Missouri, Minnesota, and Massachusetts. Methods: One hundred one patients from six investigational sites had implantation of an SI-30NB or SI-40NB IOL. Investigators evaluated the clinical acceptability of the Unfolder by comparing their experience with the injector with that using other implantation systems. Internal incision size (dimensions) was measured three times during surgery using a calibrated instrument. Data on safety and efficacy were collected. Results: The investigators rated the Unfolder as clinically acceptable. Mean internal incision size after phacoemulsification but before IOL implantation was 3.0 mm ± 0.1 (SD) (range 2.7 to 3.2 mm). Average internal incision size after IOL implantation was 3.1 ± 0.1 mm. There were no reports of haptic deformation, lens optic damage, or postoperative complications related to the Unfolder. No adverse events were reported. Conclusions: Investigators found the Unfolder easy to use. It provided controlled lens implantation through incisions 2.7 to 3.2 mm, with post-IOL implantation incisions ranging from 2.9 to 3.3 mm.
C02	`01`	`X`		`@0 002B25B`
C03	`01`	`X`	`FRE`	`@0 Lentille intraoculaire @5 01`
C03	`01`	`X`	`ENG`	`@0 Intraocular lens @5 01`
C03	`01`	`X`	`SPA`	`@0 Lente intraocular @5 01`
C03	`02`	`X`	`FRE`	`@0 Implantation @5 02`
C03	`02`	`X`	`ENG`	`@0 Implantation @5 02`
C03	`02`	`X`	`SPA`	`@0 Implantación @5 02`
C03	`03`	`X`	`FRE`	`@0 Technique @5 03`
C03	`03`	`X`	`ENG`	`@0 Technique @5 03`
C03	`03`	`X`	`SPA`	`@0 Técnica @5 03`
C03	`04`	`X`	`FRE`	`@0 Appareil @5 04`
C03	`04`	`X`	`ENG`	`@0 Apparatus @5 04`
C03	`04`	`X`	`SPA`	`@0 Aparato @5 04`
C03	`05`	`X`	`FRE`	`@0 Déploiement @5 05`
C03	`05`	`X`	`ENG`	`@0 Unfolding @5 05`
C03	`05`	`X`	`SPA`	`@0 Despliegue @5 05`
C03	`06`	`X`	`FRE`	`@0 Efficacité @5 07`
C03	`06`	`X`	`ENG`	`@0 Efficiency @5 07`
C03	`06`	`X`	`GER`	`@0 Wirkungsgrad @5 07`
C03	`06`	`X`	`SPA`	`@0 Eficacia @5 07`
C03	`07`	`X`	`FRE`	`@0 Sécurité @5 08`
C03	`07`	`X`	`ENG`	`@0 Safety @5 08`
C03	`07`	`X`	`GER`	`@0 Sicherheit @5 08`
C03	`07`	`X`	`SPA`	`@0 Seguridad @5 08`
C03	`08`	`X`	`FRE`	`@0 Homme @5 10`
C03	`08`	`X`	`ENG`	`@0 Human @5 10`
C03	`08`	`X`	`SPA`	`@0 Hombre @5 10`
C07	`01`	`X`	`FRE`	`@0 Chirurgie @5 37`
C07	`01`	`X`	`ENG`	`@0 Surgery @5 37`
C07	`01`	`X`	`SPA`	`@0 Cirugía @5 37`
N21				`@1 019`

Format Inist (serveur)

NO :	PASCAL 98-0039954 INIST
ET :	Clinical evaluation of the Unfolder
AU :	OLSON (R.); CAMERON (R.); HOVIS (T.); HUNKELER (J.); LINDSTROM (R.); STEINERT (R.)
AF :	University of Utah/Salt Lake City, Utah/Etats-Unis (1 aut.); Abilene Regional Medical Center/Abilene, Texas/Etats-Unis (2 aut.); Columbus Community Hospital/Columbus, Texas/Etats-Unis (3 aut.); University of Kansas/Kansas City/Kansas City, Missouri/Etats-Unis (4 aut.); Phillips Eye Institute/Minneapolis, Minnesota/Etats-Unis (5 aut.); Harvard Medical School/Boston, Massachusetts/Etats-Unis (6 aut.)
DT :	Publication en série; Niveau analytique
SO :	Journal of cataract and refractive surgery; ISSN 0886-3350; Coden JCSUEV; Etats-Unis; Da. 1997; Vol. 23; No. 9; Pp. 1384-1389; Bibl. 5 ref.
LA :	Anglais
EA :	Purpose: To evaluate the clinical acceptability of the Unfolder for implantation of AMO® PhacoFlex II® (model SI-30NB or SI-40NB) intraocular lenses (lOLs). Setting: Six investigational sites in five states in the United States: Utah, Texas, Missouri, Minnesota, and Massachusetts. Methods: One hundred one patients from six investigational sites had implantation of an SI-30NB or SI-40NB IOL. Investigators evaluated the clinical acceptability of the Unfolder by comparing their experience with the injector with that using other implantation systems. Internal incision size (dimensions) was measured three times during surgery using a calibrated instrument. Data on safety and efficacy were collected. Results: The investigators rated the Unfolder as clinically acceptable. Mean internal incision size after phacoemulsification but before IOL implantation was 3.0 mm ± 0.1 (SD) (range 2.7 to 3.2 mm). Average internal incision size after IOL implantation was 3.1 ± 0.1 mm. There were no reports of haptic deformation, lens optic damage, or postoperative complications related to the Unfolder. No adverse events were reported. Conclusions: Investigators found the Unfolder easy to use. It provided controlled lens implantation through incisions 2.7 to 3.2 mm, with post-IOL implantation incisions ranging from 2.9 to 3.3 mm.
CC :	002B25B
FD :	Lentille intraoculaire; Implantation; Technique; Appareil; Déploiement; Efficacité; Sécurité; Homme
FG :	Chirurgie
ED :	Intraocular lens; Implantation; Technique; Apparatus; Unfolding; Efficiency; Safety; Human
EG :	Surgery
GD :	Wirkungsgrad; Sicherheit
SD :	Lente intraocular; Implantación; Técnica; Aparato; Despliegue; Eficacia; Seguridad; Hombre
LO :	INIST-20937.354000079687470160
ID :	98-0039954

Links to Exploration step

Pascal:98-0039954

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Clinical evaluation of the Unfolder</title>
<author><name sortKey="Olson, R" sort="Olson, R" uniqKey="Olson R" first="R." last="Olson">R. Olson</name>
<affiliation><inist:fA14 i1="01"><s1>University of Utah</s1>
<s2>Salt Lake City, Utah</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cameron, R" sort="Cameron, R" uniqKey="Cameron R" first="R." last="Cameron">R. Cameron</name>
<affiliation><inist:fA14 i1="02"><s1>Abilene Regional Medical Center</s1>
<s2>Abilene, Texas</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hovis, T" sort="Hovis, T" uniqKey="Hovis T" first="T." last="Hovis">T. Hovis</name>
<affiliation><inist:fA14 i1="03"><s1>Columbus Community Hospital</s1>
<s2>Columbus, Texas</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hunkeler, J" sort="Hunkeler, J" uniqKey="Hunkeler J" first="J." last="Hunkeler">J. Hunkeler</name>
<affiliation><inist:fA14 i1="04"><s1>University of Kansas/Kansas City</s1>
<s2>Kansas City, Missouri</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lindstrom, R" sort="Lindstrom, R" uniqKey="Lindstrom R" first="R." last="Lindstrom">R. Lindstrom</name>
<affiliation><inist:fA14 i1="05"><s1>Phillips Eye Institute</s1>
<s2>Minneapolis, Minnesota</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Steinert, R" sort="Steinert, R" uniqKey="Steinert R" first="R." last="Steinert">R. Steinert</name>
<affiliation><inist:fA14 i1="06"><s1>Harvard Medical School</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0039954</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 98-0039954 INIST</idno>
<idno type="RBID">Pascal:98-0039954</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001637</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Clinical evaluation of the Unfolder</title>
<author><name sortKey="Olson, R" sort="Olson, R" uniqKey="Olson R" first="R." last="Olson">R. Olson</name>
<affiliation><inist:fA14 i1="01"><s1>University of Utah</s1>
<s2>Salt Lake City, Utah</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cameron, R" sort="Cameron, R" uniqKey="Cameron R" first="R." last="Cameron">R. Cameron</name>
<affiliation><inist:fA14 i1="02"><s1>Abilene Regional Medical Center</s1>
<s2>Abilene, Texas</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hovis, T" sort="Hovis, T" uniqKey="Hovis T" first="T." last="Hovis">T. Hovis</name>
<affiliation><inist:fA14 i1="03"><s1>Columbus Community Hospital</s1>
<s2>Columbus, Texas</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hunkeler, J" sort="Hunkeler, J" uniqKey="Hunkeler J" first="J." last="Hunkeler">J. Hunkeler</name>
<affiliation><inist:fA14 i1="04"><s1>University of Kansas/Kansas City</s1>
<s2>Kansas City, Missouri</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lindstrom, R" sort="Lindstrom, R" uniqKey="Lindstrom R" first="R." last="Lindstrom">R. Lindstrom</name>
<affiliation><inist:fA14 i1="05"><s1>Phillips Eye Institute</s1>
<s2>Minneapolis, Minnesota</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Steinert, R" sort="Steinert, R" uniqKey="Steinert R" first="R." last="Steinert">R. Steinert</name>
<affiliation><inist:fA14 i1="06"><s1>Harvard Medical School</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
<imprint><date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Apparatus</term>
<term>Efficiency</term>
<term>Human</term>
<term>Implantation</term>
<term>Intraocular lens</term>
<term>Safety</term>
<term>Technique</term>
<term>Unfolding</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lentille intraoculaire</term>
<term>Implantation</term>
<term>Technique</term>
<term>Appareil</term>
<term>Déploiement</term>
<term>Efficacité</term>
<term>Sécurité</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose: To evaluate the clinical acceptability of the Unfolder for implantation of AMO® PhacoFlex II® (model SI-30NB or SI-40NB) intraocular lenses (lOLs). Setting: Six investigational sites in five states in the United States: Utah, Texas, Missouri, Minnesota, and Massachusetts. Methods: One hundred one patients from six investigational sites had implantation of an SI-30NB or SI-40NB IOL. Investigators evaluated the clinical acceptability of the Unfolder by comparing their experience with the injector with that using other implantation systems. Internal incision size (dimensions) was measured three times during surgery using a calibrated instrument. Data on safety and efficacy were collected. Results: The investigators rated the Unfolder as clinically acceptable. Mean internal incision size after phacoemulsification but before IOL implantation was 3.0 mm ± 0.1 (SD) (range 2.7 to 3.2 mm). Average internal incision size after IOL implantation was 3.1 ± 0.1 mm. There were no reports of haptic deformation, lens optic damage, or postoperative complications related to the Unfolder. No adverse events were reported. Conclusions: Investigators found the Unfolder easy to use. It provided controlled lens implantation through incisions 2.7 to 3.2 mm, with post-IOL implantation incisions ranging from 2.9 to 3.3 mm.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0886-3350</s0>
</fA01>
<fA02 i1="01"><s0>JCSUEV</s0>
</fA02>
<fA03 i2="1"><s0>J. cataract refractive surg.</s0>
</fA03>
<fA05><s2>23</s2>
</fA05>
<fA06><s2>9</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Clinical evaluation of the Unfolder</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>OLSON (R.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CAMERON (R.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HOVIS (T.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HUNKELER (J.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LINDSTROM (R.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>STEINERT (R.)</s1>
</fA11>
<fA14 i1="01"><s1>University of Utah</s1>
<s2>Salt Lake City, Utah</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Abilene Regional Medical Center</s1>
<s2>Abilene, Texas</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Columbus Community Hospital</s1>
<s2>Columbus, Texas</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>University of Kansas/Kansas City</s1>
<s2>Kansas City, Missouri</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Phillips Eye Institute</s1>
<s2>Minneapolis, Minnesota</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Harvard Medical School</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20><s1>1384-1389</s1>
</fA20>
<fA21><s1>1997</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20937</s2>
<s5>354000079687470160</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1998 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>5 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>98-0039954</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Journal of cataract and refractive surgery</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Purpose: To evaluate the clinical acceptability of the Unfolder for implantation of AMO® PhacoFlex II® (model SI-30NB or SI-40NB) intraocular lenses (lOLs). Setting: Six investigational sites in five states in the United States: Utah, Texas, Missouri, Minnesota, and Massachusetts. Methods: One hundred one patients from six investigational sites had implantation of an SI-30NB or SI-40NB IOL. Investigators evaluated the clinical acceptability of the Unfolder by comparing their experience with the injector with that using other implantation systems. Internal incision size (dimensions) was measured three times during surgery using a calibrated instrument. Data on safety and efficacy were collected. Results: The investigators rated the Unfolder as clinically acceptable. Mean internal incision size after phacoemulsification but before IOL implantation was 3.0 mm ± 0.1 (SD) (range 2.7 to 3.2 mm). Average internal incision size after IOL implantation was 3.1 ± 0.1 mm. There were no reports of haptic deformation, lens optic damage, or postoperative complications related to the Unfolder. No adverse events were reported. Conclusions: Investigators found the Unfolder easy to use. It provided controlled lens implantation through incisions 2.7 to 3.2 mm, with post-IOL implantation incisions ranging from 2.9 to 3.3 mm.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B25B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Lentille intraoculaire</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Intraocular lens</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Lente intraocular</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Implantation</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Implantation</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Implantación</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Technique</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Technique</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Técnica</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Appareil</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Apparatus</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Aparato</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Déploiement</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Unfolding</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Despliegue</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Efficacité</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Efficiency</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="GER"><s0>Wirkungsgrad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Eficacia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Sécurité</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Safety</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="GER"><s0>Sicherheit</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Seguridad</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Chirurgie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Surgery</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Cirugía</s0>
<s5>37</s5>
</fC07>
<fN21><s1>019</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 98-0039954 INIST</NO>
<ET>Clinical evaluation of the Unfolder</ET>
<AU>OLSON (R.); CAMERON (R.); HOVIS (T.); HUNKELER (J.); LINDSTROM (R.); STEINERT (R.)</AU>
<AF>University of Utah/Salt Lake City, Utah/Etats-Unis (1 aut.); Abilene Regional Medical Center/Abilene, Texas/Etats-Unis (2 aut.); Columbus Community Hospital/Columbus, Texas/Etats-Unis (3 aut.); University of Kansas/Kansas City/Kansas City, Missouri/Etats-Unis (4 aut.); Phillips Eye Institute/Minneapolis, Minnesota/Etats-Unis (5 aut.); Harvard Medical School/Boston, Massachusetts/Etats-Unis (6 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of cataract and refractive surgery; ISSN 0886-3350; Coden JCSUEV; Etats-Unis; Da. 1997; Vol. 23; No. 9; Pp. 1384-1389; Bibl. 5 ref.</SO>
<LA>Anglais</LA>
<EA>Purpose: To evaluate the clinical acceptability of the Unfolder for implantation of AMO® PhacoFlex II® (model SI-30NB or SI-40NB) intraocular lenses (lOLs). Setting: Six investigational sites in five states in the United States: Utah, Texas, Missouri, Minnesota, and Massachusetts. Methods: One hundred one patients from six investigational sites had implantation of an SI-30NB or SI-40NB IOL. Investigators evaluated the clinical acceptability of the Unfolder by comparing their experience with the injector with that using other implantation systems. Internal incision size (dimensions) was measured three times during surgery using a calibrated instrument. Data on safety and efficacy were collected. Results: The investigators rated the Unfolder as clinically acceptable. Mean internal incision size after phacoemulsification but before IOL implantation was 3.0 mm ± 0.1 (SD) (range 2.7 to 3.2 mm). Average internal incision size after IOL implantation was 3.1 ± 0.1 mm. There were no reports of haptic deformation, lens optic damage, or postoperative complications related to the Unfolder. No adverse events were reported. Conclusions: Investigators found the Unfolder easy to use. It provided controlled lens implantation through incisions 2.7 to 3.2 mm, with post-IOL implantation incisions ranging from 2.9 to 3.3 mm.</EA>
<CC>002B25B</CC>
<FD>Lentille intraoculaire; Implantation; Technique; Appareil; Déploiement; Efficacité; Sécurité; Homme</FD>
<FG>Chirurgie</FG>
<ED>Intraocular lens; Implantation; Technique; Apparatus; Unfolding; Efficiency; Safety; Human</ED>
<EG>Surgery</EG>
<GD>Wirkungsgrad; Sicherheit</GD>
<SD>Lente intraocular; Implantación; Técnica; Aparato; Despliegue; Eficacia; Seguridad; Hombre</SD>
<LO>INIST-20937.354000079687470160</LO>
<ID>98-0039954</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001637 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001637 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    HapticV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:98-0039954
   |texte=   Clinical evaluation of the Unfolder
}}

This area was generated with Dilib version V0.6.23.
Data generation: Mon Jun 13 01:09:46 2016. Site generation: Wed Mar 6 09:54:07 2024

	Serveur d'exploration sur les dispositifs haptiques
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les dispositifs haptiques

Clinical evaluation of the Unfolder

Clinical evaluation of the Unfolder

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri